Bone morphogenetic protein excipients: comparative observations on poloxamer

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Autogeneic bone grafts are standard in reconstructive surgery but have limitations.
• Synthetic bioimplants and effective delivery vehicles for bone morphogenetic protein (BMP) are sought to overcome these limitations.
• Decades of research focus on optimizing BMP delivery for bone development.

Purpose of the Study:

• To evaluate and compare the efficacy of various carriers for delivering bone morphogenetic protein (BMP) in inducing bone development.
• To identify the optimal carrier for BMP delivery in bone reconstructive surgery applications.

Main Methods:

• Sixty-three mice received 126 implants, with BMP delivered via six different carriers or a control.
• Carriers tested included human tendon collagen, demineralized bone matrix, hydroxyapatite, and Poloxamer 407 composites.
• Implants were assessed using quantitative radiomorphometry and validated by histomorphometric analysis.

Main Results:

• Radiographic evaluation showed no significant differences among the tested carriers.
• Histomorphometric analysis revealed Poloxamer 407 as significantly more effective in delivering BMP compared to other carriers.
• New bone formation presented in tubular or spherical shapes, indicating localized osteogenesis.

Conclusions:

• Poloxamer 407 demonstrates superior performance as a BMP delivery vehicle for bone regeneration.
• The interaction between endogenous and exogenous systems is crucial for optimal BMP transmission.
• Further research into BMP localization and transmission mechanisms may lead to safer alternatives to autogeneic bone grafts.